




Searching News Database: sleep apnea
HSMN NewsFeed - 5 Sep 2024
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
HSMN NewsFeed - 28 Feb 2018
SnoreRx, Now Available at CVS, is First and Only FDA Certified Non-prescription Anti Snoring Treatment
SnoreRx, Now Available at CVS, is First and Only FDA Certified Non-prescription Anti Snoring Treatment
HSMN NewsFeed - 18 Dec 2017
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
HSMN NewsFeed - 10 Jul 2017
Philips-sponsored Study Suggests Positive Airway Pressure Therapy Could Reduce COPD Patient Hospitalization
Philips-sponsored Study Suggests Positive Airway Pressure Therapy Could Reduce COPD Patient Hospitalization
HSMN NewsFeed - 17 May 2017
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
HSMN NewsFeed - 28 Apr 2017
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
HSMN NewsFeed - 12 Jan 2017
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
HSMN NewsFeed - 9 Feb 2016
LifeWatch(TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
LifeWatch(TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
HSMN NewsFeed - 18 Jan 2016
LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch
HSMN NewsFeed - 6 Feb 2015
Sorin Group Receives Regulatory Approval for New Generation MRI Compatible Pacing System in Japan
Sorin Group Receives Regulatory Approval for New Generation MRI Compatible Pacing System in Japan
HSMN NewsFeed - 10 Nov 2014
ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device
ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device
HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
HSMN NewsFeed - 27 Nov 2013
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
HSMN NewsFeed - 9 Oct 2013
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
Preventice, Inc. Receives CE Mark for BodyGuardian Remote Monitoring System
HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
HSMN NewsFeed - 11 Dec 2012
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.
HSMN NewsFeed - 27 Nov 2012
Jay Millerhagen Joins Respicardia(R) as Vice President of Clinical Affairs and Market Development
Jay Millerhagen Joins Respicardia(R) as Vice President of Clinical Affairs and Market Development
HSMN NewsFeed - 21 Sep 2012
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
VIVUS Provides Update on the Review of the Qsiva Marketing Authorization Application
HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
HSMN NewsFeed - 7 Mar 2011
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
HSMN NewsFeed - 30 Nov 2010
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
HSMN NewsFeed - 10 Nov 2010
Satiety’s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
Satiety’s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 22 Apr 2010
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
Outcomes of Patients Dismissed from the Hospital with Noncardiac Chest Pain
HSMN NewsFeed - 26 Mar 2010
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity
HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
HSMN NewsFeed - 15 Mar 2010
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
HSMN NewsFeed - 11 Jan 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
HSMN NewsFeed - 5 Oct 2009
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
HSMN NewsFeed - 23 Sep 2009
ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA
ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA
HSMN NewsFeed - 13 Aug 2009
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
HSMN NewsFeed - 27 May 2009
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
HSMN NewsFeed - 16 Apr 2009
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
HSMN NewsFeed - 23 Mar 2009
Covidien Receives FDA Clearance for the Nellcor OxiMax N-600x Pulse Oximeter with OxiMax SPD Alert
Covidien Receives FDA Clearance for the Nellcor OxiMax N-600x Pulse Oximeter with OxiMax SPD Alert
HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
HSMN NewsFeed - 21 Sep 2008
Portability of Sleep Apnea Treatment Devices Provides Uninterrupted Rest Without the Hassle
Portability of Sleep Apnea Treatment Devices Provides Uninterrupted Rest Without the Hassle
HSMN NewsFeed - 15 Aug 2008
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
HSMN NewsFeed - 5 Jun 2008
Covidien Launches Sandman Info(TM) and Sandman Auto(TM) CPAP Devices in the United States
Covidien Launches Sandman Info(TM) and Sandman Auto(TM) CPAP Devices in the United States
HSMN NewsFeed - 13 Feb 2008
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
HSMN NewsFeed - 21 Dec 2007
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
HSMN NewsFeed - 15 Oct 2007
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
HSMN NewsFeed - 4 Oct 2007
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
HSMN NewsFeed - 18 Sep 2007
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
HSMN NewsFeed - 14 Jun 2007
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
HSMN NewsFeed - 22 May 2007
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
HSMN NewsFeed - 24 Apr 2007
SPO Medical Enhances Its Compact Wrist-Mounted Oximetry System for Pre-Screening of Sleep Apnea Symptoms
SPO Medical Enhances Its Compact Wrist-Mounted Oximetry System for Pre-Screening of Sleep Apnea Symptoms
HSMN NewsFeed - 6 Mar 2007
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
HSMN NewsFeed - 7 Feb 2007
Portable Somnoscreen Sleep-Monitoring System (Somnoscreen PSG) Approved for U.S. Sales
Portable Somnoscreen Sleep-Monitoring System (Somnoscreen PSG) Approved for U.S. Sales
HSMN NewsFeed - 5 Jan 2007
Hypnion Announces Positive and Robust Phase II Results for Novel Sleep Drug - HY10275
Hypnion Announces Positive and Robust Phase II Results for Novel Sleep Drug - HY10275
HSMN NewsFeed - 5 Oct 2006
Six New Studies Document Efficacy and Sustained Benefit of Restore Medical's Pillar(R) Procedure
Six New Studies Document Efficacy and Sustained Benefit of Restore Medical's Pillar(R) Procedure
HSMN NewsFeed - 21 Sep 2006
Vital Signs, Inc. Announces FDA Clearance to Market Sleep and Ventilation Products
Vital Signs, Inc. Announces FDA Clearance to Market Sleep and Ventilation Products
Additional items found! 103

Members Archive contains
103 additional stories matching:
sleep apnea
(Password required)
sleep apnea
(Password required)